Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United States subsidiary, Medicure Pharma Inc. The Company also operates Marley Drug, Inc. (Marley Drug), a pharmacy located in North Carolina that offers an Extended Supply drug program serving all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving the health status of its patients and the communities they serve while reducing overall health care costs for employers and other health care consumers. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by rex50on Jun 07, 2014 9:43pm

268 Views

Post# 22640582

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Earnings

Totally agree. Aggrastat has 55% of market share in Europe. If it captures 20 % of market share (300 million) by end of calendar year 2014 , it would have 15 million $ in quarterly revenue and excellent net profit of over $2 a share per year. Grossly UNDERVALUED imo

Bullboard Posts

How a junior advances one of the largest undeveloped diamond projects